Ben R Taylor
CIK 1712276 · View on SEC EDGAR ↗
First SEC filing: Dec. 2, 2024 · Latest: June 17, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 17, 2026 | RXRX | F | 25,018 | $3.16 | $79,057 | 1,076,858 Direct | -2.27% | Disposed | 6.0% (price as of 2026-08-20) |
| June 15, 2026 | RXRX | F | 5,396 | $3.15 | $16,997 | 1,101,876 Direct | -0.49% | Disposed | 6.4% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Initial ownership (Form 3) 12 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Dec. 2, 2024 | RXRX | Class A Common Stock | 61,870 | Direct |
| Dec. 2, 2024 | RXRX | Class A Common Stock | 75,375 | Direct |
| Dec. 2, 2024 | RXRX | Class A Common Stock | 21,199 | Direct |
| Dec. 2, 2024 | RXRX | Class A Common Stock | 102,186 | Direct |
| Dec. 2, 2024 | RXRX | Class A Common Stock | 63,867 | Direct |
| Dec. 2, 2024 | RXRX | Class A Common Stock | 71,294 | Direct |
| Dec. 2, 2024 | RXRX | Class A Common Stock | 81,479 | Direct |
| Dec. 2, 2024 | RXRX | Class A Common Stock | 4,830 | Direct |
| Dec. 2, 2024 | RXRX | Class A Common Stock | 14,492 | Direct |
| Dec. 2, 2024 | RXRX | Stock Option (Right to Buy)→ Class A Common Stock (289,837) | 289,837 | Direct |
| Dec. 2, 2024 | RXRX | Stock Option (Right to Buy)→ Class A Common Stock (92,748) | 92,748 | Direct |
| Dec. 2, 2024 | RXRX | Stock Option (Right to Buy)→ Class A Common Stock (81,154) | 81,154 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
RXRX
CFO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $538,680 | — | $253,881 | $323,110 | $205,226 | — | $7,586 | $1,328,483 |
| 2024 | $53,392 | — | $2,255,389 | $5,662,543 | $200,327 | — | — | $8,171,651 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.